Bill Head
Algemeen Adviseur bij Consumer Healthcare Products Association
Actieve functies van Bill Head
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Consumer Healthcare Products Association | Algemeen Adviseur | 07-01-2011 | - |
| Public Communications Contact | 07-01-2011 | 07-01-2011 |
Loopbaan van Bill Head
Eerdere bekende functies van Bill Head
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Algemeen Adviseur | 04-02-2011 | 04-02-2011 |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| General Counsel | 2 |
| Public Communications Contact | 1 |
Sectoraal
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
| Consumer Healthcare Products Association | |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
